查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363099

缺鐵性貧血治療市場規模、佔有率、趨勢分析報告：按治療類型、年齡層、最終用戶、地區和細分市場預測，2023-2030 年

Iron Deficiency Anemia Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Oral Iron Therapy, Parenteral Iron Therapy), By Age Group, By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

缺鐵性貧血治療市場的成長與趨勢：

Grand View Research 的一項新研究顯示，到 2030 年，全球缺鐵性貧血治療市場規模預計將達到 80.6 億美元。

預計2023年至2030年該市場將以7.6%的年複合成長率成長。月經異常大量出血和產後出血病例數量的增加是推動年輕女性擴大採用 IDA 治療的主要要素。此外，女性營養健康意識的提高、腸外營養補充劑的進步、新產品的推出等是推動缺鐵性貧血（IDA）治療市場成長的關鍵要素。

根據美國國家醫學圖書館 2023 年 3 月更新的報告，月經的年度患病每 1,000 名女性 53 人。美國國家醫學圖書館於 2018 年 6 月發表的另一篇論文發現，在停經年齡層中，約 5% 至 10% 的月經病例是由經痛（月經量多）等月經失調引起的。此外，在發展中國家，更年期婦女普遍缺鐵，月經是加劇因素，導致嚴重貧血。

公眾意識的提高、地方政府對女性營養健康的策略性舉措、腸外營養補充劑的進步、新產品的推出等是全球IDA治療市場成長的關鍵促進因素。例如，在印度，除了中央政府的 Anemia Mukt Bharat 計畫外，喀拉拉邦政府於 2023 年 2 月啟動了一項計劃。該活動旨在六個月內覆蓋全州約 1300 萬名女性。進行了挨家挨戶的活動，以測試和實施階段干涉措施，以減輕貧血負擔。

行業領導者正在尋求合作和收購來加強產品系列。例如，2022年11月，CSL Vifor和Fresenius Kabi宣布其靜脈注射鐵劑藥物Ferinject獲得中國國家藥監局核准用於治療成人鐵缺乏症患者。當口服製劑無效或不合適，或臨床上需要快速給藥時，就需要使用 Ferinject。當時，兩家公司計劃於2023年上半年開始銷售Ferinject，預計2024年1月在85個國家獲得上市核准，並在國家健保目錄上市。這為我們增加市場佔有率和擴大全球患者使用 Ferinject 的機會提供了機會。同樣，2021年7月，山德士推出了經濟高效的Ferumoxytol注射液，這是美國首個治療缺鐵性貧血的學名藥大劑量靜脈注射鐵劑治療藥物。

缺鐵性貧血治療市場報告亮點

  • 整個缺鐵性貧血治療市場的成長是由全球缺鐵性貧血患病不斷上升所推動的。
  • 它對於患有慢性或不太嚴重的缺鐵性貧血的患者特別有吸引力。
  • 2022 年，依治療方法類型分類，腸外鐵劑治療佔最大。這是由於腸外鐵劑製劑的進步以及該市場主要企業推出的新產品。
  • 2022 年，成人年齡層細分市場佔據最大銷售佔有率，達到 63.87%。這是因為忙碌的生活方式和不良飲食導致成人缺鐵性貧血的廣泛患病。
  • 由於多個主要企業的存在以及政府為克服該地區缺鐵性貧血負擔而提供的越來越多的支持，北美在 2022 年佔據了市場主導地位。
  • 市場上的主要企業正在採取新產品發布、合作夥伴關係和聯盟等策略來擴大其全球影響力。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第4章 處理類型業務分析

  • 缺鐵性貧血治療市場：治療類型變化分析
  • 口服鐵劑治療
  • 腸外鐵劑治療
  • 紅血球輸注
  • 其他

第5章 按年齡分類的業務分析

  • 缺鐵性貧血治療市場：年齡層變化分析
  • 成人
  • 兒童
  • 老年人

第6章 最終使用者的業務分析

  • 缺鐵性貧血治療市場：最終用戶變化分析
  • 診所
  • 醫院
  • 家庭保健

第7章 區域業務分析

  • 2022年及2030年缺鐵性貧血治療市場佔有率（按地區）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 參與企業
  • 策略規劃
    • 新產品發布
    • 合夥
    • 合作
  • 2022年主要企業市場佔有率分析
  • 公司簡介
    • Akebia Therapeutics, Inc.
    • Bayer AG
    • PHARMACOSMOS A/S
    • Sanofi
    • Johnson &Johnson Services, Inc.
    • CSL Vifor
    • AbbVie Inc.（Allergan）
    • Novartis AG
    • Teoxane
    • Zydus Group
    • GSK plc
    • AdvaCare Pharma
    • Apotex Inc.
    • Covis Pharma GmbH
Product Code: GVR-4-68040-124-0

Iron Deficiency Anemia Therapy Market Growth & Trends:

The global iron deficiency anemia therapy market size is expected to reach USD 8.06 billion by 2030, as per a new study by Grand View Research, Inc.. The market is projected to grow at a CAGR of 7.6% from 2023 to 2030. Rising cases of abnormally heavy bleeding during menstruation and post-partum hemorrhage are some major factors increasing the adoption rate of IDA therapy in young women. Moreover, rising awareness for women's nutritional health, advancing parenteral nutrition supplements, and novel product launches are some key drivers fueling the market growth for iron deficiency anemia (IDA) therapy.

According to a National Library of Medicine report updated in March 2023, the annual prevalence of menorrhagia is 53 per 1,000 women. Another article published by the National Library of Medicine in June 2018 states that menstrual disorders such as menorrhagia (heavy menstrual blood loss) contribute to approximately 5-10% of cases of IDA in the perimenopausal age group. Moreover, in developing countries where nutritional iron deficiency is already prevalent among perimenopausal women, menorrhagia is an exacerbating factor, leading to severe anemia.

Rising awareness among people and strategic initiatives by regional governments for women's nutritional health, advancing parenteral nutrition supplements, and novel product launches are some of the key driving factors for the global IDA therapy market growth. For instance, in February 2023, in India, the Kerala state government launched its initiative in addition to the Centre's Anaemia Mukt Bharat program. The campaign aimed to reach around 13 million women across the state within six months. A door-to-door campaign was conducted to test and implement graded interventions to reduce the burden of anemia.

Industry leaders are involved in collaborations & acquisitions to enhance their product portfolios. For instance, in November 2022, CSL Vifor and Fresenius Kabi announced that Ferinject, an intravenous iron therapy, had received approval from China's NMPA for treating iron deficiency in adult patients. Ferinject is indicated for cases where oral preparations are ineffective or unsuitable or when rapid iron delivery is clinically necessary. At the time, the companies planned to commence marketing Ferinject in the first half of 2023, with the approval marking its marketing authorization in 85 countries, along with an anticipated NRDL listing in January 2024. This represents an opportunity for enhanced market presence and expanded patient access to Ferinject globally. Similarly, in July 2021, Sandoz launched a cost-effective Ferumoxytol injection, the first generic intravenous high-dosage iron for treating IDA in the U.S.

Iron Deficiency Anemia Therapy Market Report Highlights:

  • The growth of the overall IDA therapy market is attributed to the increasing prevalence of anemia associated with iron deficiency across the globe
  • The market is witnessing a key shift with the rise in preference for home healthcare settings, which is especially appealing to those with chronic or less severe cases of iron deficiency anemia
  • Parenteral iron therapy held the largest share in terms of therapy type in 2022. This is owing to the advancements in parenteral iron formulations and new product launches by key companies operating in the market
  • The adult age group segment held the largest revenue share of 63.87% in 2022. This is attributed to busy lifestyles and improper diets contributing to the extensive prevalence of iron deficiency anemia in adults
  • North America dominated the market in 2022, owing to the presence of several key players and rising support from governments for overcoming the burden of IDA in the region
  • Key players in the market are adopting strategies such as new product launches, partnerships, and collaborations, among others to expand their global geographical reach

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation And Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Therapy Type Segment
      • 1.1.1.2. Age Group Segment
      • 1.1.1.3. End-User Segment
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Or Data Analysis
  • 1.7. Market Model
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Therapy Type and Age Group Snapshot
  • 2.3. End-user Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing global elderly population
      • 3.2.1.2. Increasing prevalence of iron deficiency anemia
      • 3.2.1.3. Growing government initiatives to overcome the burden of iron deficiency
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Side effects associated with certain IDA therapies
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Therapy Type Business Analysis

  • 4.1. Iron Deficiency Anemia Therapy Market: Therapy Type Movement Analysis
  • 4.2. Oral Iron Therapy
    • 4.2.1. Oral Iron Therapy Market, 2018 - 2030 (USD Million)
  • 4.3. Parenteral Iron Therapy
    • 4.3.1. Parenteral Iron Therapy Market, 2018 - 2030 (USD Million)
  • 4.4. Red Blood Cell Transfusion
    • 4.4.1. Red Blood Cell Transfusion Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Age Group Business Analysis

  • 5.1. Iron Deficiency Anemia Therapy Market: Age Group Movement Analysis
  • 5.2. Adults
    • 5.2.1. Adults Market, 2018 - 2030 (USD Million)
  • 5.3. Pediatric
    • 5.3.1. Pediatric Market, 2018 - 2030 (USD Million)
  • 5.4. Geriatric
    • 5.4.1. Geriatric Market, 2018 - 2030 (USD Million)

Chapter 6. End-User Business Analysis

  • 6.1. Iron Deficiency Anemia Therapy Market: End-User Movement Analysis
  • 6.2. Clinics
    • 6.2.1. Clinics Market, 2018 - 2030 (USD Million)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.4. Home Healthcare
    • 6.4.1. Home Healthcare Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Iron Deficiency Anemia Therapy Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. U.S. Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Canada Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. UK Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Germany Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. France Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Italy Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Spain Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Denmark Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Sweden Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Norway Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Japan Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. China Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. India Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Australia Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Thailand Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. South Korea Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Brazil Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Mexico Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Argentina Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. South Africa Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Saudi Arabia Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. UAE Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Kuwait Iron Deficiency Anemia Therapy Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Collaboration
  • 8.3. Key Company Market Share Analysis, 2022
  • 8.4. Company Profiles
    • 8.4.1. Akebia Therapeutics, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Bayer AG
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. PHARMACOSMOS A/S
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Sanofi
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Johnson & Johnson Services, Inc.
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. CSL Vifor
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. AbbVie Inc. (Allergan)
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Novartis AG
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Teoxane
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Zydus Group
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. GSK plc
      • 8.4.11.1. Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. AdvaCare Pharma
      • 8.4.12.1. Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Strategic Initiatives
    • 8.4.13. Apotex Inc.
      • 8.4.13.1. Overview
      • 8.4.13.2. Financial Performance
      • 8.4.13.3. Product Benchmarking
      • 8.4.13.4. Strategic Initiatives
    • 8.4.14. Covis Pharma GmbH
      • 8.4.14.1. Overview
      • 8.4.14.2. Financial Performance
      • 8.4.14.3. Product Benchmarking
      • 8.4.14.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Iron Deficiency Anemia Therapy Market, By Therapy Type, 2018 - 2030 (USD Million)
  • Table 4 Global Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 5 Global Iron Deficiency Anemia Therapy Market, By End-User, 2018 - 2030 (USD Million)
  • Table 6 Global Iron Deficiency Anemia Therapy Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 North America Iron Deficiency Anemia Therapy Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Iron Deficiency Anemia Therapy Market, By Therapy Type, 2018 - 2030 (USD Million)
  • Table 9 North America Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 10 North America Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 11 US Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 12 US Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 13 US Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 14 Canada Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 16 Canada Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 17 Europe Iron Deficiency Anemia Therapy market, by Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 19 Europe Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 20 Europe Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 21 UK Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 22 UK Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
  • Table 23 UK Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 24 Germany Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 25 Germany Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 26 Germany Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 27 France Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 28 France Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 29 France Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 30 Italy Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 31 Italy Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 32 Italy Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 33 Spain Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 34 Spain Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 35 Spain Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 36 Denmark Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 37 Denmark Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 38 Denmark Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 39 Sweden Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 41 Sweden Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 42 Norway Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 43 Norway Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 44 Norway Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Iron Deficiency Anemia Therapy market, by country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 49 Japan Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 50 Japan Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 51 Japan Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 52 China Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 53 China Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 54 China Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 55 India Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 56 India Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 57 India Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 58 Australia Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 59 Australia Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 60 Australia Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 61 Thailand Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 62 Thailand Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 63 Thailand Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 64 South Korea Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 66 South Korea Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 67 Latin America Iron Deficiency Anemia Therapy market, by country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 69 Latin America Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 70 Latin America Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 71 Brazil Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 72 Brazil Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 73 Brazil Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 74 Mexico Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 75 Mexico Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 76 Mexico Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 77 Argentina Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 79 Argentina Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Iron Deficiency Anemia Therapy market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 84 South Africa Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 86 South Africa Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 90 UAE Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 92 UAE Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Iron Deficiency Anemia Therapy market, by End-User, 2018-2030, (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Iron deficiency anemia therapy, market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Market challenge relevance analysis (current & future impact)
  • Fig. 13 SWOT analysis
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Global iron deficiency anemia therapy market: Therapy Type movement & market share analysis
  • Fig. 16 Global iron deficiency anemia therapy market, for oral iron therapy, 2018 - 2030 (USD Million)
  • Fig. 17 Global iron deficiency anemia therapy market, for parenteral iron therapy, 2018 - 2030 (USD Million)
  • Fig. 18 Global iron deficiency anemia therapy market, for red blood cell transfusion, 2018 - 2030 (USD Million)
  • Fig. 19 Global iron deficiency anemia therapy market, for other therapies, 2018 - 2030 (USD Million)
  • Fig. 20 Global iron deficiency anemia therapy market: Age group movement & market share analysis
  • Fig. 21 Global iron deficiency anemia therapy market, for adults, 2018 - 2030 (USD Million)
  • Fig. 22 Global iron deficiency anemia therapy market, for pediatric, 2018 - 2030 (USD Million)
  • Fig. 23 Global iron deficiency anemia therapy market, for geriatric, 2018 - 2030 (USD Million)
  • Fig. 24 Global iron deficiency anemia therapy market: End-user movement & market share analysis
  • Fig. 25 Global iron deficiency anemia therapy market, for clinics, 2018 - 2030 (USD Million)
  • Fig. 26 Global iron deficiency anemia therapy market, for hospitals, 2018 - 2030 (USD Million)
  • Fig. 27 Global iron deficiency anemia therapy market, for home healthcare, 2018 - 2030 (USD Million)
  • Fig. 28 Regional marketplace: key takeaways
  • Fig. 29 Regional outlook, 2022 & 2030
  • Fig. 30 Global iron deficiency anemia therapy market: region movement analysis
  • Fig. 31 North America iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 32 US key country dynamics
  • Fig. 33 US iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada key country dynamics
  • Fig. 35 Canada iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 37 UK key country dynamics
  • Fig. 38 UK iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany key country dynamics
  • Fig. 40 Germany iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 41 France key country dynamics
  • Fig. 42 France iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy key country dynamics
  • Fig. 44 Italy iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain key country dynamics
  • Fig. 46 Spain iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark key country dynamics
  • Fig. 48 Denmark iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden key country dynamics
  • Fig. 50 Sweden iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 51 Norway key country dynamics
  • Fig. 52 Norway iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan key country dynamics
  • Fig. 55 Japan iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 56 China key country dynamics
  • Fig. 57 China iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 58 India key country dynamics
  • Fig. 59 India iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 60 Australia key country dynamics
  • Fig. 61 Australia iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand key country dynamics
  • Fig. 63 Thailand iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea key country dynamics
  • Fig. 65 South Korea iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil key country dynamics
  • Fig. 68 Brazil iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 69 Mexico key country dynamics
  • Fig. 70 Mexico iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 71 Argentina key country dynamics
  • Fig. 72 Argentina iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 73 Middle East and Africa iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 74 South Africa key country dynamics
  • Fig. 75 South Africa iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 76 Saudi Arabia key country dynamics
  • Fig. 77 Saudi Arabia iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 78 UAE key country dynamics
  • Fig. 79 UAE iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 80 Kuwait key country dynamics
  • Fig. 81 Kuwait iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
  • Fig. 82 Company market position analysis
  • Fig. 83 Company/competition categorization
  • Fig. 84 Strategy mapping